Next Article in Journal
Immunological Aspects of Human Papilloma Virus-Related Cancers Always Says, “I Am like a Box of Complexity, You Never Know What You Are Gonna Get”
Next Article in Special Issue
What Factors Are Associated with Attitudes towards HPV Vaccination among Kazakhstani Women? Exploratory Analysis of Cross-Sectional Survey Data
Previous Article in Journal
Governmental Incentives, Satisfaction with Health Promotional Materials, and COVID-19 Vaccination Uptake among Community-Dwelling Older Adults in Hong Kong: A Random Telephone Survey
Previous Article in Special Issue
Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019–2020
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Immunity after HPV Vaccination in Patients after Sexual Initiation

by
Dominik Pruski
1,2,*,
Małgorzata Łagiedo-Żelazowska
3,4,
Sonja Millert-Kalińska
1,4,
Jan Sikora
3,
Robert Jach
5 and
Marcin Przybylski
1,2
1
Department of Obstetrics and Gynecology, District Public Hospital in Poznan, 60-479 Poznań, Poland
2
Gynecology Specialised Practise, 60-408 Poznań, Poland
3
Department of Immunology, Chair of Pathomorphology and Clinical Immunology, Poznan University of Medical Sciences, 60-806 Poznań, Poland
4
Doctoral School, Poznan University of Medical Sciences, 61-701 Poznań, Poland
5
Department of Gynecological Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland
*
Author to whom correspondence should be addressed.
Vaccines 2022, 10(5), 728; https://doi.org/10.3390/vaccines10050728
Submission received: 28 March 2022 / Revised: 3 May 2022 / Accepted: 4 May 2022 / Published: 6 May 2022
(This article belongs to the Collection HPV-Vaccines)

Abstract

Vaccinations against human papillomavirus (HPV) are included in the primary prevention of precancerous intraepithelial lesions and HPV-related cancers. Despite the undeniable effectiveness of vaccination in the juvenile population, there is still little research on the effect in patients after sexual initiation. Our study aims to assess anti-HPV (L1 HPV) antibodies in healthy patients and diagnosed cervical pathology after 9-valent vaccination. We provide a prospective, ongoing 12-month, non-randomised pilot study in which 89 subjects were enrolled. We used an enzyme-linked immunosorbent assay to determine IgG class antibodies to HPV. We noted significantly higher levels of antibodies in vaccinated individuals than in the unvaccinated control group. The above work shows that vaccination against HPV might be beneficial in patients after sexual initiation as well as in those already diagnosed with HPV or SIL infection.
Keywords: HPV serum antibodies; L1 HPV; 9-valent vaccination; squamous intraepithelial neoplasia HPV serum antibodies; L1 HPV; 9-valent vaccination; squamous intraepithelial neoplasia

Share and Cite

MDPI and ACS Style

Pruski, D.; Łagiedo-Żelazowska, M.; Millert-Kalińska, S.; Sikora, J.; Jach, R.; Przybylski, M. Immunity after HPV Vaccination in Patients after Sexual Initiation. Vaccines 2022, 10, 728. https://doi.org/10.3390/vaccines10050728

AMA Style

Pruski D, Łagiedo-Żelazowska M, Millert-Kalińska S, Sikora J, Jach R, Przybylski M. Immunity after HPV Vaccination in Patients after Sexual Initiation. Vaccines. 2022; 10(5):728. https://doi.org/10.3390/vaccines10050728

Chicago/Turabian Style

Pruski, Dominik, Małgorzata Łagiedo-Żelazowska, Sonja Millert-Kalińska, Jan Sikora, Robert Jach, and Marcin Przybylski. 2022. "Immunity after HPV Vaccination in Patients after Sexual Initiation" Vaccines 10, no. 5: 728. https://doi.org/10.3390/vaccines10050728

APA Style

Pruski, D., Łagiedo-Żelazowska, M., Millert-Kalińska, S., Sikora, J., Jach, R., & Przybylski, M. (2022). Immunity after HPV Vaccination in Patients after Sexual Initiation. Vaccines, 10(5), 728. https://doi.org/10.3390/vaccines10050728

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop